Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2013; 19(14): 2242-2248
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2242
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2242
Table 3 Adverse effects among the 262 patients n (%)
| Adverse effect | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
| Nausea/vomiting | 160 (61.1) | 48 (18.3) | - (-) | - (-) |
| General fatigue | 28 (10.7) | 17 (6.5) | 1 (0.4) | - (-) |
| Fever | 168 (64.1) | 27 (10.3) | - (-) | - (-) |
| Abdominal pain | 121 (46.1) | 54 (20.6) | - (-) | - (-) |
| Leucopenia | 13 (4.9) | 2 (0.7) | - (-) | - (-) |
| Thrombocytopenia | 16 (6.1) | 2 (0.7) | - (-) | - (-) |
| AST/ALT | 154 (58.8) | 46 (17.6) | - (-) | - (-) |
| Liver abscess | - (-) | 2 (0.7) | 2 (0.7) | - (-) |
| Hepatic/Renal failure | - (-) | - (-) | 1 (0.4) | - (-) |
- Citation: Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Takikawa Y, Suzuki K. Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol 2013; 19(14): 2242-2248
- URL: https://www.wjgnet.com/1007-9327/full/v19/i14/2242.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i14.2242